Researchers at the MUHC in Montreal have documented a severe case of internal hemorrhaging in a patient that drank chamomile tea and used chamomile lotion while taking anti-coagulant medication for a heart condition. The 70-year old patient was admitted to the MUHC ER in Montreal after using chamomile to help soothe her sore throat. The case published in the Canadian Medical Association Journal (CMAJ) this week, highlights the need for caution when taking alternative (natural) therapies while on physician prescribed medications.
The patient had been implanted with a mechanical valve and was taking an anti-coagulant medication called warfarin, designed to thin the blood and reduce the chances of stroke. "Warfarin is an effective and reliable anti-coagulant and as a result is used commonly," says Dr. Louise Pilote an internist and epidemiologist at the MUHC and Associate Professor of Medicine at McGill University. "We are aware of several herbal products that should not be taken with warfarin, such as garlic, onion and ginger, but this is the first time we have documented a life-threatening reaction when combined with chamomile."
Warfarin is derived from coumarin, a chemical compound with anti-coagulant properties found in many plants, including chamomile. "It seems the chamomile acted synergistically with the warfarin in this case," says Dr. Pilote. "Although this is a rare case, it highlights the potential dangers of mixing herbal remedies with physician prescribed medications."
Camomile tea is taken to treat a range of ailments including toothache, sore thoats, digestive problems and insomnia-it is known as the night-time tea because it acts as a mild sedative. Camomile lotion is often used to treat skin conditions psoriasis, eczema and acne as well as helping soothe insect bites.
The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. The MUHC is a merger of five teaching hospitals affiliated with the Faculty of Medicine at McGill University--the Montreal Childrens, Montreal General, Royal Victoria, and Montreal Neurological Hospitals, as well as the Montreal Chest Institute. Building on the tradition of medical leadership of the founding hospitals, the goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field, and to contribute to the development of new knowledge.
Ian Popple | MUHC
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Earth Sciences
05.12.2016 | Physics and Astronomy
05.12.2016 | Life Sciences